Bastien Hermans
Managing Director, Healthcare Mid-Cap
In Portfolio
IPL
IPL is a leading UK-based provider of infection prevention devices for patients on long-term vascular access treatment.
Overview
IPL manufactures and distributes patented, single-use prescription shower and water activity protection products for renal and oncology patients on central venous access devices (CVADs). Infections in this patient population are frequent and can lead to severe, potentially life-threatening complications, while also driving significant treatment costs for healthcare systems
HQ
IPL is headquartered in the UK.
Global Sales
IPL serves over 4,000 renal and oncology patients across Europe.
Healthcare sector2026 Entry into PortfolioFund Astorg Mid-Cap65 EMPLOYEESHealthcare sector2026 Entry into PortfolioFund Astorg Mid-Cap65 EMPLOYEESHealthcare sector2026 Entry into PortfolioFund Astorg Mid-Cap65 EMPLOYEESHealthcare sector2026 Entry into PortfolioFund Astorg Mid-Cap65 EMPLOYEES
Meet the team behind our deep
expertise and market-leading results
Chris Benson
Partner, Head of Business Services & Head of UK Mid-Cap
Joris Plöns
Associate, Mid-Cap
Recent News
ViewMore
Astorg completes acquisition of Microbiology business from Thermo Fisher Scientific, establishing an independent global diagnostics specialist
Aug 12, 2026
ViewMore
Astorg-backed CordenPharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform
Jun 4, 2026
ViewMore
Astorg-backed Steliau to acquire Acal BFI, strengthening its position as the leading European platform in value-added electronic solutions
Jun 1, 2026
